Clinical Trial Update: The Role of mGluR5 in CBT-I [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating the role of mGluR5 modulation in CBT-I for adults with Major depressive disorder, currently recruiting at Stony Br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Stony Brook University | Conditions: Major Depressive Disorder (MDD) | Phase 4 | Status: RECRUITING